Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue $ 11,246,000 $ 8,882,000
Cost of revenue 4,497,000 3,812,000
Gross profit 6,749,000 5,070,000
Operating expenses:    
Sales and marketing 7,305,000 7,752,000
Research and development 2,748,000 2,474,000
General and administrative 10,524,000 7,702,000
Loss on impairment of goodwill 0 189,000
Restructuring 0 244,000
Total operating expenses 20,577,000 18,361,000
Loss from operations (13,828,000) (13,291,000)
Other (expense) income, net:    
Interest expense (113,000) (139,000)
Warrant issuance expense 0 (329,000)
Gain (loss) on revaluation of warrant liabilities 3,962,000 (3,056,000)
Gain on forgiveness of note payable 1,099,000 0
Other (expense) income, net (884,000) 990,000
Total other income (expense), net 4,064,000 (2,534,000)
Net loss (9,764,000) (15,825,000)
Foreign currency translation adjustments 830,000 (897,000)
Comprehensive loss $ (8,934,000) $ (16,722,000)
Basic net loss per share applicable to common shareholders (in dollars per share) $ (0.80) $ (2.21)
Diluted net loss per share applicable to common shareholders (in dollars per share) $ (0.88) $ (2.21)
Weighted-average number of shares outstanding, basic (in shares) 12,193 7,164
Weighted average number of shares outstanding, diluted (in shares) 12,269 7,164